Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and External Validation of an Imaging-Clinical Multimodal Fusion Model for Predicting Postoperative Prognosis After Partial Nephrectomy in Patients With Endophytic Renal Cell Carcinoma

NCT07697417 is registered in ClinicalTrials.gov with Tianjin Medical University Second Hospital as lead sponsor.

NCT NCT07697417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07697417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and External Validation of an Imaging-Clinical Multimodal Fusion Model for Predicting Postoperative Prognosis After Partial Nephrectomy in Patients With Endophytic Renal Cell Carcinoma
Lead sponsor
Tianjin Medical University Second Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2026
Completion date
December 1, 2026
Enrollment
406 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endophytic renal tumor, kidney neoplasms, partial nephrectomy outcome, postoperative renal function, renal cell carcinoma